Phase IV Studies

Phase IV/Post marketing surveillance is an important stage of drug development to evaluate the effectiveness of a drug in the real world environment. Our streamlined operation team follows a lean management program to deliver quick and cost-effective solutions for such large trials.


With years of experience in conducting Phase IV studies across wide range of therapeutic areas, we have developed a business model designed exclusively to deal with Phase IV studies. The model is a combination of operational excellence, dedicated and trained project management team, flexible delivery models, customized approach and integrated technology.


Our Phase IV team has expertise in observational studies, patient registries as well as interventional Phase IV programs. Our expertise spans across different therapeutic areas, including cardiology, metabolic disorders, ophthalmology and oncology.


  • Huge regional coverage with access to sites in tier II/III cities
  • Large network of regional project managers and CRCs for rapid investigator and patient recruitment
  • Well equipped data management team to handle large volume of data with speed and efficiency
  • Established SOPs for post approval settings